Skip to main content
. 2010 Feb 11;108(5):1052–1060. doi: 10.1152/japplphysiol.00904.2009

Table 2.

In vivo data

Exchange Transfusion, ml/kg
0 10 20 30 P
Hb, g/dl 13.5 ± 1.5 12.4 ± 0.8 11.8 ± 0.4 11.4 ± 0.3 *
Hematocrit, % 40.3 ± 3.3 31.8 ± 3.8 26.5 ± 1.3 23.2 ± 1.4 *
Mean alveolar Po2, Torr 141 ± 3 141 ± 6 137 ± 7 135 ± 2
Heart rate, beats/min 119 ± 5 107 ± 11 100 ± 22 106 ± 10
Pulmonary blood flow, ml · (min · kg)−1 121 ± 5 114 ± 20 119 ± 18 109 ± 10
End-expiratory lung volume, ml/kg 32 ± 5 32 ± 5 31 ± 5 31 ± 8
End-inspiratory lung volume, ml/kg 84 ± 5 84 ± 4 83 ± 5 83 ± 8
Septal tissue volume, ml/kg 5.10 ± 2.15 4.88 ± 1.84 3.80 ± 1.45 4.30 ± 1.92
DlCO, ml · (min · Torr · kg)−1 0.61 ± 0.05 0.61 ± 0.10 0.61 ± 0.06 0.60 ± 0.03
DlNO, ml · (min · Torr · kg)−1 2.69 ± 0.44 3.01 ± 0.57 3.81 ± 0.92 4.27 ± 1.08 *
Method 1 (RF)
DmCO, ml · (min · Torr · kg)−1 1.08 ± 0.11 1.07 ± 0.23 1.21 ± 0.10 1.01 ± 0.21
Vc, ml/kg 2.75 ± 0.33 2.96 ± 0.19 2.73 ± 0.26 3.47 ± 0.64 *
Method 2 (NO-CO, θNO = ∞)
DmCO, ml · (min · Torr · kg)−1 1.15 ± 0.19 1.29 ± 0.29 1.63 ± 0.39 1.82 ± 0.46 *
Vc, ml/kg 2.57 ± 0.33 2.42 ± 0.22 2.18 ± 0.05 2.06 ± 0.35 *
Method 3 (NO-CO, θNO = 4.5)
DmCO, ml · (min · Torr · kg)−1 2.23 ± 0.70 2.68 ± 0.86 4.55 ± 2.28 4.28 ± 2.31
Vc, ml/kg 1.70 ± 0.25 1.66 ± 0.12 1.52 ± 0.06 1.66 ± 0.03

Values are means ± SD. RF, Roughton-Forster method using θCO from Eq. 4. NO-CO method assumes DlNO/DmCO = 2.34 and θNO = ∞ or θNO = 4.5. Repeated-measures ANOVA and post hoc Fisher's protected least significant difference:

*

P < 0.05 vs. exchange transfusion;

P < 0.05 vs. method 1.